Post-MDA surveillance ( including xeno-monitoring) Krishnamoorthy K. Vector Control Research Centre Pondicherry India.

Slides:



Advertisements
Similar presentations
New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Advertisements

Module 2 Eligibility for a TAS TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of.
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis Module 4 Survey design.
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis Module 1 Background.
Module 6 After the survey TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of mass.
PROGRESS REPORT: The National STH Programme in BHUTAN Mr. Sangay Thinley 2014 RPRG Meeting Jakarta, Indonesia 23 – 24 Sept
Malaria Elimination in Zanzibar. Introduction Dramatic declines in malaria morbidity and mortality over the last decade (prevalence remained
End TB strategy target setting
Module 3 Evaluation unit
Innovative community based HIV counseling and testing models for identifying new HIV positive adults and children: a case of a countrywide program in.
W: Supported by Epidemiology of sub-patent Plasmodium falciparum infection: implications for detection of hotspots.
Module 8 Survey sample builder
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
National De-Worming Day
Dr Ahmed Jamsheed Mohamed WHO South East Asia Regional Office 9-11 February 2015.
Module 1: Final Case Study #1-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 1-CS-2.
Unit 3: Sample Size, Sampling Methods, Duration and Frequency of Sampling #3-3-1.
Unit 5: Core Elements of HIV/AIDS Surveillance
Community Planning Training 1-1. Community Plan Implementation Training 1- Community Planning Training 1-3.
Combining Entomological, Epidemiological, and Space Mapping data for Malaria Risk-mapping in Northern Uganda Findings and Implications Ranjith de Alwis,
Sudan Experience on Poverty Survey Somaia K.E.Omer Date 7-8 Aug بسم الله الرحمن الرحيم.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Monitoring and Evaluation in MCH Programs and Projects MCH in Developing Countries Feb 10, 2011.
Multiple Indicator Cluster Surveys Survey Design Workshop Sampling: Overview MICS Survey Design Workshop.
Roadmap Progress Report 2011 Zambia SARN-RBM PARTNERS ANNUAL CONSULTATIVE MEETING, JULY 2011.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
United Nations Regional Workshop on the 2010 World Programme on Population and Housing Censuses: Census Evaluation and Post Enumeration Surveys Bangkok,
1 Discrepancies between National and International Data WORKSHOP ON MDG MONITORING BANGKOK, THAILAND 14 th – 16 th January 2009 By W.J.Nigamuni Deputy.
Prevention of malaria epidemics by vector control in Burundi highlands MSF UK Scientific day, 2007 Natacha Protopopoff, Dismas Baza, Michel Van Herp, Peter.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Monitoring, supervision and quality control IDSP training module for state and district surveillance officers Module 11.
Module 7 Verification of elmination TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment.
Assessing the Feasibility of Continuous Net Distribution in Kenya using Community Based Approach.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Global burden of LF Around 1.4 billion people in 73 countries at risk Over 120 million infected About 40 million disfigured and incapacitated.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases.
Update on Current Thinking Within GMP on Malaria Prevention Prepared for 4 th RBM WIN Meeting, STI, Basle October 2007 Dr S. Hoyer VCP/GMP//WHO WHO.
Progress Report: National LF and STH Programme in Nepal
Progress report: the national LF and STH programme in Thailand By Sunsanee Rojanapanus, Dr. Thitima Wongsaroj 2014 RPRG Meeting WHO Region.
Livesy Abokyi Kintampo Health Research Centre 9 th INDEPTH AGM th October,2009 Pune, INDIA.
Human resources for malaria elimination Deyer Gopinath GMS Malaria Elimination Course 10 – 21 August 2015, Chiang Mai, Thailand.
Next-Generation LLINs: Programmatic Implications Matthew Lynch October 26, 2015.
Polio Research Activities in India Dr Sunil Bahl WHO-India, NPSP 15 March 2012.
Monitoring and Evaluation in MCH Programs and Projects MCH in Developing Countries Feb 9, 2012.
Proposal on Revised Mechanism of Selecting Applications for Approval Presentation by Secretariat of Council for the AIDS Trust Fund in Sharing Session.
Mohamed Faisal 2014 RPRG Meeting WHO Region.  Geography and Population ◦ Total population: 371,507 (Census 2006) ◦ Ecological zones – next slide  Political.
Working to overcome the global impact of neglected tropical diseases Documenting the achievement of elimination as a public health problem GPELF dossier.
Strengthening SME system for national programmes from transmission reduction to elimination phase China Dr Li Xiao Hong National Program officer WHO, China.
A Presentation on the Report of the Monitoring and Evaluation Exercise conducted between 1st January - 30th June, 2011 Presented By Jil Mamza Monitoring.
Joint application package (JAP)  Joint Application Package (JAP) was rolled out as an an integrated planning tool, rather than just an application form.
SMALL GROUP DISCUSSION AMONG PARAMEDICS AT HEALTH CENTER LEVEL TO IMPROVE ADHERENCE TO STANDARD TREATMENT GUIDELINES OF ACUTE RESPIRATORY TRACT INFECTIONS.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
RESULTS MERK AFRIKA RESEARCH SUMMIT 2016
Dr. Upendo John Mwingira NTD programme manager
iCCM Recommended Indicators
TB- HIV Collaborative activities in Romania- may 2006 status
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ Unit 2 – Post test CR ES GT NI PA January.
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
STAC36 - March 2014 Design and Evaluation of a Health Educational Board Game for the Control of Soil Transmitted Helminthiasis among Primary School.
RAcE Niger Final Evaluation Results
Déirdre Hollingsworth University of Warwick
World Tuberculosis Day 2016
Global Village Debate This house would ban information dissemination on safe injecting practices, and ban the provision of clean and sterile injecting.
Training Workshop – Module 3
RTI International Daniel A. Cohn Sr Technical Advisor
Introduction to OpenMalaria
Presentation transcript:

Post-MDA surveillance ( including xeno-monitoring) Krishnamoorthy K. Vector Control Research Centre Pondicherry India

Table 2. Number of districts covered under MDA in relation to drugs No. roundsDEC alone DEC + albendazoleTotal State to review the results of Mf survey in the MDA districts every year and the districts recording less than 1% Mf prevalence in all the sentinel and spot-check sites should complete Mf survey in 10 additional sites so as to generate information before next round of MDA. MDA need not be conducted in districts recording less than 1% in all the 10 additional sites. Resources for one round of MDA can be saved.

The coverage is reported as number out of eligible population (drug coverage). Due to wide variation in the proportion of eligible population, the coverage becomes inflated. Therefore, it will be useful if the coverage is calculated out of total population. Directorate to make necessary changes in the reporting formats. Independent assessment of coverage and compliance is not carried out in many districts. This information is required to identify the gap and identify methods to bridge it. Programme governance is observed to be weak in some states. There is no feedback from the reviews at higher levels and action plans suffer. Inadequate supply of drugs was common even during last round at all level. This results in low levels of coverages. Along with activity reports, action taken reports also should be reviewed at the Directorate of NVBDCP. Drug compliance was observed to be below the threshold level in some district, warranting strong social mobilization activities.

Country Populatio n (M) Population requiring PC for LF (M) Endemi c IUs Numbe r of IUs require MDA Numbe r of IUs stoppe d MDA Numbe r of IUs require d MDA in 2012 Numbe r of IUs covere d Geograph ical coverage Total population of Ius covered (M) Reported number of people treated (M) Program me (drug) coverage Nationa l coverag e Number of IUs subjected to TAS Banglades h % %*18.7%5 India % %46.5%0 Indonesia % %19.1%24 Maldives Post MDA surveillance1 Myanmar % %0.0%5 Nepal % %29.2%0 Sri Lanka Post MDA surveillance8 Thailand Post MDA surveillance357 Timor- Leste % %0.0%0 Total % %37.5%400 Table 1. Details of MDA carried out in SEA Region during 2012

Mapping and remapping protocols Mapping protocolRe-mapping protocol Number of sites230 Selection of sitesProbable (risk)pps Target age15 yrs or older10 yrs Sample ToolMf/AgAg Cut-off1%2%

Development of an appropriate and feasible surveillance strategy to monitor the post-MDA epidemiological situation is necessary to: a)declare the areas/intervention units are free from LF transmission or b)take steps to prevent resurgence of infection, if any. Antigenaemia prevalence has been recommended to monitor post MDA situation. However, the change in this parameter during the post MDA period (five years) is not known to understand the usefulness of this indicator and also to decide on the frequency of post MDA survey. Rationale

Study area VillagesPopulation Mf prevalence Pre MDA Post 3 rounds Post 6 rounds % reduction (pre-post 6) Kallakulathur Keelidayalam Sendiampakkam Sitheni Total Intervention = Mass annual single dose DEC + albendazole Six rounds – supervised administration ( ) Coverage = above 70% Post 6 rounds of MDA = <1% mf Ag prevalence (3-6 years) = 0/93 Stopped MDA in 2008

Objectives To understand the post-MDA changes in antigenaemia prevalence in children (6-10 years) To relate the post-MDA changes in antigenaemia prevalence in children with the antigenaemia prevalence in adult groups (16-45 years) To evaluate the value of xenomonitoring as a tool for post- MDA surveillance To determine the required duration of post-MDA surveillance period

Evaluation Unit Evaluation Unit - four villages VillageHouseholdsFemaleMaleTotal Kallakulathur Keelidayalam Sendiampakkam Sitheni Grand Total

Overall 7.76 % n=580 Overall 0.05% n=585

Indicators and tools 1.Antigenemia (mass) survey in : Diagnostic tool – ICT Target age class o 6-10 years (children) o years (adults) 2.Entomological survey: 5000 vector mosquitoes Gravid traps Dissection to assess the vector infection These surveys were repeated after two years. The first survey was done in 2011 and the second in 2013

2013 Villages 6-10 years16-45 yearsTotal Sample Ag +ve%Sample Ag +ve%Sample Ag +ve% Kallakulathur Keelidayalam Sendiampakkam Sitheni Total Villages 6-10 years16-45 yearsTotal Sample Ag +ve%Sample Ag +ve%Sample Ag +ve% Kallakulathur Keelidayalam Sendiampakkam Sitheni Total

Year 6-10 years PopulationSample Coverage (%) PopulationSampleCoverage (%) 2011 (post MDA 3) (Post MDA 5) Coverage for ICT survey

Ag prevalence during post MDA

TAS exercise (6-7 years) YearPopulationSampleCoverage (%) Ag +ve

Ag survey Longitudinal (cohort) folllow-up Total = 1053 Positive in 2011 = 23 Loss in 2013= 19 (82.6%) Negative in 2011 = 1030 Gain in 2013= 15 (1.46%)

Entomological survey – (2011) VillageTraps Vector (C.q) Trap density InfectionIntensityInfectivity CollectedDissectedPositive Kalla Kulathur Sithani Keezh Edayalam Sendiampakkam Total

Entomological survey – (2013) VillagePopulatio n No. collections No. traps No. collecte d Density range per trap Per trap density No. dissecte d No. infected No. infective Sithani Keelidayalam Kallakulathur Sendiampakkam Total Period of survey3 months

Absence of recent transmission in two consecutive post-MDA surveys indicate that 1% Mf prevalence was safe to discontinue MDA. Prevalence of antigenemia prevalence among children (6-10 years) is less than 1% during post MDA period. Post-MDA Ag-prevalence between children and adult age class is not related, and therefore adult age class cannot be targeted for evaluation. There was reduction in antigenemia prevalence in both children (28%) and adult age classes (33%). The relative change in Ag prevalence between the age classes was also not significant. Loss of infection was about 83%. Xenomonitoring after two years of stopping MDA did not show evidence for vector infection implying absence of potential mf carriers in the study community. Conclusion

Achieving the sample size (census) Migrant children Assessing school enrolment rates “hotspots” Challenges in implementing TAS